mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NC_000913_3_bme_pgi | 4,296,061 | 0 | C | T | 28.9% | 44.1 / 19.8 | 39 | intergenic (+266/+376) | gltP/yjcO | glutamate/aspartate:proton symporter/Sel1 family TPR‑like repeat protein |
| * | NC_000913_3_bme_pgi | 526,792 | 0 | A | C | 23.3% | 75.5 / 17.2 | 43 | S1178R (AGC→CGC) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 526,800 | 0 | A | G | 22.5% | 77.3 / 16.9 | 42 | E1180E (GAA→GAG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 526,796 | 0 | C | G | 20.5% | 85.0 / 17.3 | 40 | A1179G (GCG→GGG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| Marginal new junction evidence (lowest skew 10 of 66 shown) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NC_000913_3_bme_pgi | = 2305071 | NA (NA) | 5 (0.190) | 5/250 | 3.0 | NA | noncoding (655/655 nt) | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences |
| ? | NC_000913_3_bme_pgi | = 2305100 | NA (NA) | intergenic (+707/+8) | eco/mqo | ecotin, a serine protease inhibitor/malate dehydrogenase, FAD/NAD(P)‑binding domain | |||||
| * | ? | NC_000913_3_bme_pgi | 3782590 = | 33 (1.100) | 5 (0.180) | 5/270 | 3.3 | 14.1% | intergenic (‑28/+52) | cysE/gpsA | serine acetyltransferase/glycerol‑3‑phosphate dehydrogenase (NAD+) |
| ? | NC_000913_3_bme_pgi | 3782613 = | 30 (1.060) | intergenic (‑51/+29) | cysE/gpsA | serine acetyltransferase/glycerol‑3‑phosphate dehydrogenase (NAD+) | |||||
| * | ? | NC_000913_3_bme_pgi | 349884 = | 34 (1.140) | 5 (0.180) | 5/272 | 3.3 | 12.6% | noncoding (280/365 nt) | REP25 (repetitive extragenic palindromic) element; contains 8 REP sequences | REP25 (repetitive extragenic palindromic) element; contains 8 REP sequences |
| ? | NC_000913_3_bme_pgi | 349916 = | 37 (1.300) | noncoding (312/365 nt) | REP25 (repetitive extragenic palindromic) element; contains 8 REP sequences | REP25 (repetitive extragenic palindromic) element; contains 8 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | = 225895 | NA (NA) | 7 (0.250) | 5/272 | 3.3 | NA | noncoding (137/2904 nt) | rrlH | 23S ribosomal RNA of rrnH operon |
| ? | NC_000913_3_bme_pgi | = 225899 | NA (NA) | noncoding (141/2904 nt) | rrlH | 23S ribosomal RNA of rrnH operon | |||||
| * | ? | NC_000913_3_bme_pgi | 3437896 = | 18 (0.600) | 4 (0.150) | 4/262 | 3.6 | 20.8% | intergenic (+2/‑128) | trkA/mscL | NAD‑binding component of TrK potassium transporter/mechanosensitive channel protein, high conductance |
| ? | NC_000913_3_bme_pgi | 3437924 = | 14 (0.510) | intergenic (+30/‑100) | trkA/mscL | NAD‑binding component of TrK potassium transporter/mechanosensitive channel protein, high conductance | |||||
| * | ? | NC_000913_3_bme_pgi | = 1536866 | 40 (1.340) | 4 (0.140) | 4/266 | 3.6 | 9.9% | coding (444/696 nt) | narW | nitrate reductase 2 (NRZ), delta subunit (assembly subunit) |
| ? | NC_000913_3_bme_pgi | = 1536879 | 36 (1.290) | coding (431/696 nt) | narW | nitrate reductase 2 (NRZ), delta subunit (assembly subunit) | |||||
| * | ? | NC_000913_3_bme_pgi | 3652866 = | NA (NA) | 5 (0.180) | 4/268 | 3.7 | 19.5% | coding (333/1017 nt) | insH1 | IS5 transposase and trans‑activator |
| ? | NC_000913_3_bme_pgi | 3828131 = | 22 (0.730) | coding (535/1206 nt) | gltS | glutamate transporter | |||||
| * | ? | NC_000913_3_bme_pgi | = 3281708 | 48 (1.600) | 4 (0.140) | 4/272 | 3.7 | 7.7% | noncoding (7/82 nt) | REP239 (repetitive extragenic palindromic) element; contains 2 REP sequences | REP239 (repetitive extragenic palindromic) element; contains 2 REP sequences |
| ? | NC_000913_3_bme_pgi | = 3281726 | 50 (1.760) | noncoding (25/82 nt) | REP239 (repetitive extragenic palindromic) element; contains 2 REP sequences | REP239 (repetitive extragenic palindromic) element; contains 2 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | = 2219631 | NA (NA) | 4 (0.140) | 4/272 | 3.7 | 11.1% | noncoding (7/34 nt) | REP152 (repetitive extragenic palindromic) element; contains 1 REP sequences | REP152 (repetitive extragenic palindromic) element; contains 1 REP sequences |
| ? | NC_000913_3_bme_pgi | = 4153558 | 32 (1.120) | noncoding (212/346 nt) | REP309 (repetitive extragenic palindromic) element; contains 6 REP sequences | REP309 (repetitive extragenic palindromic) element; contains 6 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | = 2219631 | NA (NA) | 4 (0.140) | 4/272 | 3.7 | 9.5% | noncoding (7/34 nt) | REP152 (repetitive extragenic palindromic) element; contains 1 REP sequences | REP152 (repetitive extragenic palindromic) element; contains 1 REP sequences |
| ? | NC_000913_3_bme_pgi | = 4153435 | 38 (1.330) | noncoding (89/346 nt) | REP309 (repetitive extragenic palindromic) element; contains 6 REP sequences | REP309 (repetitive extragenic palindromic) element; contains 6 REP sequences | |||||